Sexual and Reproductive Health

At Women’s College Hospital, we are addressing the complexity of effectively delivering reproductive health services that are impacted by science, sociocultural issues and politics. Our scientist are leading efforts to enhance access to abortion services, provide up-to-date and accessible information about emergency contraception options and enhance quality of care for women living with HIV.

Women and HIV

Despite HIV increasingly being recognized as a chronic and manageable disease, women living with HIV face unique medical, social, and political obstacles, including pervasive HIV-related stigma. Dr. Mona Loutfy founded The Women and HIV Research Program (WHRP) in 2006 and partnered with women living with HIV to address their unique clinical needs. WHRP is guided by principles of feminism, equity, anti-oppression, anti-racism and social justice, as well as the “Meaningful Engagement of Women Living with HIV/AIDS (MEWA).”

WHRP aims to accomplish three primary goals: 1) finalize a new model of care (the Women-centred HIV Care Model) aimed at optimizing the health and wellbeing of women with HIV in Canada, particularly those most affected by HIV including Indigenous women and trans women; 2) disseminate and optimize implementation of the 2018 Canadian HIV Pregnancy Planning Guidelines; and 3) mentor and train the next generation of researchers and clinicians that are focused on health equity for women with and at risk of HIV. 

Abortion Care and Contraception

Ensuring that women have equal access to specialized health services, especially when it comes to their reproductive health, is fundamental to their overall well-being. Dr. Sheila Dunn is the Associate Director of Research for the Contraception and Abortion Research Team- Groupe de recherche sur l’avortement et la contraception (CART-GRAC), a national, interdisciplinary collaboration that conducts research to support health services and policies to promote equitable access to high-quality family planning knowledge, methods and services for people throughout Canada. CART research has informed federal, and provincial policies for contraception and abortion services and methods, health professional licensing policies, and national clinical guidelines.

Dr. Dunn and team have a particular research focus on mifepristone abortion or medication abortion, which became available in Canada in 2017. Currently the team is investigating how the dissemination of mifepristone to community primary care can enhance access to abortion, particularly as it relates to geographic disparities. With the CART team Dr. Dunn is also studying changes in abortion practice, safety and cost associated with mifepristone availability.

Areas of Focus and Key Findings

Publications

The Canadian HIV Women’s Sexual and Reproductive Health Cohort

The Canadian HIV Pregnancy Planning Guidelines (CHPPG)

Trans Women HIV Research Initiative

  • HIV care among transgender women living with HIV (doi:10.1111/hiv.13261)
  • ‘Transgender Education for Affirmative and Competent HIV and Healthcare (TEACHH)’ (doi:10.1136/bmjopen-2019-034144)
  • Barriers to HIV prevention, treatment and support (doi:10.1111/hsc.13234)
  • Mental health (doi:10.1080/09540121.2020.1737640)
  • Gender-affirming healthcare experiences (doi:10.1071/SH19011)
  • HIV Care Cascade (doi:10.1089/apc.2019.0013)

Abortion Care and Access

  • Renner RM, Ennis M, Contandriopoulos D, Guilbert E, Dunn S, Kaczorowski J, Darling EK, Albert A, Styffe C, Norman WV. Abortion services and providers in Canada in 2019: Results of a national survey. CMAJ Open Sep 2022, 10 (3) E856-E864; DOI: 10.9778/cmajo.20210232.
  • Dunn S, Munro S, Devane C, Guilbert E, Jeong D, Stroulia E, Soon JA, Norman WV. A virtual community of practice to support physician uptake of a novel abortion practice: A mixed methods case study. J Med Internet Res 2022;24(5):e34302
  • Schummers L, McGrail K, Darling EK, Dunn S, Gayowsky A, Kaczorowski J, Norman, WV. A more accurate approach to define abortion cohorts using linked administrative data: an application to Ontario, Canada. International Journal of Population Data Science 2022; 7(1). doi: 10.23889/ijpds.v7i1.1700.
  • Ennis M, Renner R, Guilbert E, Norman WV, Pymar H, Kean L, Carson A, Martin-Misener, Dunn S. Provision of first-trimester medication abortion in 2019: Results from the Canadian Abortion Provider Survey. Contraception 2022; doi: https://doi.org/10.1016/j.contraception.2022.03.020
  • Schummers, L., McGrail K., Darling E K, Dunn S, Gayowsky A, Kaczorowski J, Norman WV. (2022) “A more accurate approach to define abortion cohorts using linked administrative data: an application to Ontario, Canada”, International Journal of Population Data Science, 7(1). doi: 10.23889/ijpds.v7i1.1700
  • Schummers L, Darling EK, Dunn S, McGrail K, Carson A, Gayowsky A, Law MR, Laba TL, Kaczorowski J, Norman WV. Abortion safety and use with normally prescribed mifepristone in Canada. NEJM 2022; 386:57-67.